Infantile Qishen reinfection granule and preparation method thereof

Abstract

The invention relates to an infantile Qishen reinfection granule and a preparation method thereof. The infantile Qishen reinfection granule is prepared from 323.3 to 343.3 g of roasted astragalus membranaceus, 190.0 to 210.0 g of radix salviae miltiorrhizae, 190.0 to 210.0 g of bran-fried rhizoma atractylodis macrocephalae, 190.0 to 210.0 g of pericarpium citri reticulatae, 323.3 to 343.3 g of radix pseudostellariae, 190.0 to 210.0 g of radix paeoniae rubra, 123.3 to 143.3 g of rhizoma chuanxiong and 190.0 to 210.0 g of vinegar-processed endothelium corneum gigeriae galli. The infantile Qishen reinfection granule is a qi-tonifying, blood-activating and spleen-activating formula, the treatment effect on infantile recurrent respiratory tract infection is verified, the effect is remarkable, the formula consists of eight traditional Chinese medicines such as roasted astragalus membranaceus, radix pseudostellariae, radix salviae miltiorrhizae and ligusticum wallichii, and the formula pays attention to qi-tonifying, blood-activating and spleen-activating and highlights the traditional Chinese medicine theory of 'collaterals entering after long illness'; the treatment rule of promoting blood circulation to remove meridian obstruction is realized while the body resistance is strengthened; and clinical tests for many years show that the curative effect is exact.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a pediatric Qishen Fugan granule and a preparation method thereof. Background technique [0002] Recurrent respiratory tract infection (RRTI) is a common and frequently-occurring disease in infants and young children. The incidence rate accounts for about 30% of respiratory tract infections in pediatric outpatient clinics, and patients with respiratory tract infection account for about 80% of the total number of pediatric outpatients. According to the RRTI diagnostic criteria formulated by the National Academic Conference on Pediatric Respiratory Diseases in 1987, children with upper or lower respiratory tract infections within a year exceeding a certain range are identified as children with recurrent respiratory tract infections, referred to as recurrent children. Its clinical manifestations vary depending on the site of infection, and are generally consistent with the correspo...

AI Technical Summary

Problems solved by technology

At present, there is no specific medicine for the treatment of RRTI in western medicine. During the acute infection period, antibiotics are mainly used to control the course of the disease from the perspective of symptomatic treatment. During the recovery period after infection, supplementing trace elements and regulating immunity can enhance the immune defense function of reinfected children. , in order to reduce the number of recurrent infections, but Western medicine often has the disadvantages of poor curative effect and many side effects.

Images